Acid suppressants and hip fracture: Duplicate publication bias?

Bone

Volumn 49, Issue 4, 2011, Pages 920-

  Bazelier, Marloes ^a   de Boer, Anthonius ^a   De Vries, Frank ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACID SUPPRESSANT; DIGESTIVE TRACT AGENT; ONDANSETRON; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG;

DATA ANALYSIS; DATA BASE; DISEASE ASSOCIATION; DRUG EFFICACY; HIP FRACTURE; HUMAN; LETTER; META ANALYSIS (TOPIC); NAUSEA AND VOMITING; PUBLISHING; SENSITIVITY ANALYSIS;

FRACTURES, BONE; HISTAMINE H2 ANTAGONISTS; HUMANS; PROTON PUMP INHIBITORS;

EID: 80052289873     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2011.07.025     Document Type: Letter

References (6)

1. Kwok C.S., Yeong J.K.Y., Loke Y.K. Meta-analysis: risk of fractures with acid-suppressing medication. Bone 2011, 48(4):768-776.
2. de Vries F., Cooper A.L., Cockle S.M., van Staa T.P., Cooper C. Fracture risk in patients receiving acid-suppressant medication alone and in combination with bisphophonates. Osteoporos Int 2009, 20(12):1989-1998.
3. Yang Y.-X., Lewis J.D., Epstein S., Metz D.C. Long term proton pump inhibitor therapy and risk of hip fractures. JAMA 2006, 296(24):2947-2953.
4. Kaye J.A., Jick H. Proton pump inhibitor use and risk of hip fractures in patients without major risk factors. Pharmacotherapy 2008, 28(8):951-959.
5. Egger M., Davey-Smith G. Meta-analysis. Bias in location and selection of studies. BMJ 1998, 316(7124):61-66.
6. Tramèr M.R., Reynolds D.J., Moore R.A., McQuay H.J. Impact of covert duplicate publication on meta-analysis: a case study. BMJ 1997, 315:635-640.